Approximately 60% of the NUTM2A-AS1::RP11-203L2.4 containing tumor cells were solely identified by long-read evidence, another 20% by short reads only, and the remaining 20% by both short and long reads (Fig. 7B). The gene discussed is NUTM2A; the disease is neoplasm.